| Literature DB >> 36211073 |
Hongmei Wang1,2, Shengbao Duan1,2, Yezhou Chen1,2, Huan Liu3, Jingjing Tian1, Feiran Wu2, Ziqian Du2, Longhai Tang4, Yong Li1,2, Shaohua Ding1,2.
Abstract
The development of immunosensing assays for in vitro diagnostics has attracted great attention in recent years. Various substrate materials and immobilization methods of biomolecules were exploited for immunosensors, but their bioactivity and longevity have been facing serious challenges. To address this limitation, we investigated a natural silk cocoon membrane as immunosensing substrate material. By using its intrinsic properties, the target biomolecules were immobilized on the membrane through directional immunoaffinity recognition. The silk cocoon membrane-based immunosensor showed great potential for both qualitative and quantitative immunoassays, through naked-eye observation or analyzing the change in red color intensity, respectively. The immunosensor exhibited significant detection capability for anti-D (titer 1:1024) sensitized red blood cells. The colorimetric responses of concentrations ranged from 1 μg/mL to 1 ng/mL, and the detection limit for anti-D was 3.4 ng/mL. The immunosensor also showed excellent stability for the immobilized antibodies when stored at 4 and 25 °C; the bioactivity remained unchanged or slightly declined within 40 weeks. Even at 37 °C, the bioactivity began to decline after 12 weeks. This current work highlights the potential of using the natural silk cocoon membrane as a substrate for a versatile and thermally stable immunosensing platform for application in immunoassays.Entities:
Year: 2022 PMID: 36211073 PMCID: PMC9535715 DOI: 10.1021/acsomega.2c04777
Source DB: PubMed Journal: ACS Omega ISSN: 2470-1343
Scheme 1Schematic Representation of SMD-Based Immunosensing Platform Fabrication and Application
Figure 1Characterization of the stepwise fabrication process of the SMD-based immunosensing platform. (A) Colorimetric ELISA assays to confirm the binding of 2H3 and GAM-IgG on the SMD; (B) confocal laser scanning microscopy images to confirm the binding of 2H3 and GAM-IgG on the SMD; and (C) AFM images to confirm the binding of 2H3 and GAM-IgG on the SMD. (i) Naked SMDs as the blank control, (ii) SMD/2H3, and (iii) SMD/2H3/GAM-IgG.
Figure 2Determination of the optimal binding concentration of antibodies using colorimetric ELISA. (A) SMD/2H3 and (B) SMD/2H3/GAM-IgG. (i) Digital images of the colorimetric ELISA responses. (ii) Quantitative analysis of the ΔRed color intensity of the different binding concentrations with linear regression.
Figure 3Analytical performance of the SMD immunosensor for the detection of IgG anti-D. (A) Detection of anti-D with the SMD-based immunosensing platform and tube test. (i) Different dilutions of anti-D sensitization of RBCs as the analytes on the SMD-based immunosensing platform; (ii) dilutions of anti-D determined by tube test. (B) Detection principle of anti-D sensitization of RBCs on the SMD-based immunosensing platform. (C) The colorimetric responses of different concentrations ranging from 1 μg/mL to 1 ng/mL using the SMD-based immunosensor. (i) Digital images of the colorimetric responses of anti-D; (ii) linear regression equations for detection of anti-D between low- and high-concentration calibration plots.
Figure 4Long-term stability of the SMD-based immunosensing platform stored at different temperatures. (A) Digital images of the colorimetric responses of the SMD/2H3/GAM-IgG/MAH-IgG for the detection of anti-D; (B) quantitative measurement of the ΔRed color intensity of the anti-D detection with linear regression.
Figure 5Thermal stability of the SMD-based immunosensor with blood typing antibodies at different storage conditions.